We're Leaders in
World Class Medical Research
You can help
January 12, 2017 – CAF National President Anthony J. Viola shares his thoughts on the state of CAF as the new year begins:
A Happy and a Healthy New Year to our Cooley’s Anemia Foundation Family, Friends, and Supporters.
2017 (wow, lol) is upon us and as I am coming to the end of my ninth year as National President, I feel that the Foundation and the outlook for our patients in the near future is all going in the right direction.
2016 was an extremely successful year in terms of accomplishments and in the improvement of the Foundation’s infrastructure that will pay dividends down the road:
After attending the American Society of Hematology’s Annual Conference (“ASH”) in December, 2016, it is clear that the next 3-5 years will be an exciting time period for potential new patient treatment options. As a side note, our 2016 CAF-ApoPharma Distinguished Scholar recipient, Aaron Cheng, was a presenter at ASH, a very proud moment for the Cheng family and for CAF. Michael Spino, President of ApoPharma, which funds this scholarship program, was also in attendance to hear Aaron’s presentation. Congratulations to Aaron and to the Cheng family, and thank you to ApoPharma for their generous support of this very important scholarship program.
With all the good that 2016 has presented to us, we are always reminded of the additional work that lies ahead of us to try and make our patients’ lives even better. Unfortunately we still lose patients way too early in their lives, though, thankfully, that rate of loss has declined rapidly over the past 15 years. And while patients are indeed living longer, they are experiencing “new issues” that must be medically addressed, hence the importance of our work as a Foundation to keep moving forward.
All in all, I am very pleased as to where we are as a Foundation and as to where we are headed in the near future. CAF continues to be the leading thalassemia patient advocate in the world. CAF is the only organization that provides direct patient services to thalassemia patients in the United States. In general, 80% of every dollar received by CAF is used for the benefit of our patients, whether it is through the research grants that we fund, invaluable patient services, public information to expand awareness, etc.
As the leading representative of the Cooley’s Anemia Foundation, please allow me to thank all our supporters, volunteers (including the Board of Directors and the Executive Committee), and our fine staff for all the hard work that has been done and continues to be done.
And on a personal note, I would like to thank all my friends and family who have supported CAF for many, many years. Your efforts are always appreciated by me, the patients, and CAF, and it is my honor to be National President of this great organization that has done fantastic work for over 60 years. You have inspired me to continue to keep moving forward with the hope that one day we will realize a true cure to thalassemia for all our patients. But in the meantime, please know the positive impact that you have on these extraordinary people that have to deal with a medical condition on a daily basis but who not only endure, but exceed the boundaries of their medical issues to strive for excellence every single day.
God bless all of our Cooley’s Anemia Family.
Anthony J. Viola
CAF National President